Core Laboratories Inc. /DE/ (CLB) intrinsic value & 10-year financials
Core Laboratories Inc. /DE/ (CLB) has a Graham intrinsic value of $13.32 per share. At $10.00 on Oct 17, 2026, the stock trades 25% below that value. Over the last 6 fiscal years revenue grew 2.9% a year to $526.5M, with an average return on invested capital of 13.2%.
- Graham intrinsic value
- $13.32
- Share price (Oct 17, 2026)
- $10.00
- Price vs Graham value
- 25% below
- Market cap
- $470.3M
- Revenue (FY2025)
- $526.5M
- Revenue growth (6-yr CAGR)
- 2.9%
- ROIC (10-yr avg)
- 13.2%
- Free cash flow (FY2025)
- $25.8M
CLB 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $526.5M | $29.7M | $0.63 | $25.8M | 10.7% | 10.4% |
| FY2024 | $523.8M | $31.4M | $0.66 | $43.4M | 11.2% | 11.1% |
| FY2023 | $509.8M | $36.7M | $0.77 | $14.2M | 10.7% | 15.3% |
| FY2022 | $489.7M | $19.5M | $0.42 | $14.7M | 8.5% | 8.0% |
| FY2021 | $470.3M | $19.7M | $0.42 | $23.0M | 9.6% | 21.2% |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Core Laboratories Inc. /DE/ revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Core Laboratories Inc. /DE/ returns on capital have been average, hovering around 11.2% ROIC over the decade.
Core Laboratories Inc. /DE/ capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Core Laboratories Inc. /DE/ is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $13.32 per share.